Mood disorders in patients with cancer

The Lancet Oncology

Volumn 12, Issue 2, 2011, Pages 114-115

  Wasteson, Elisabet ^a  

^a MID SWEDEN UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEPRESSION; DISEASE ASSOCIATION; GENETIC HETEROGENEITY; HEALTH CARE SYSTEM; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; MOOD DISORDER; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SOCIOECONOMICS; SURVIVAL TIME;

HUMANS; MOOD DISORDERS; NEOPLASMS;

EID: 79251478034     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70007-9     Document Type: Letter

References (5)

1. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011, 12:160-174.
2. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. New Engl J Med 2010, 363:733-742.
3. Kaasa S, Loge JH, Fayers P, et al. Symptom assessment in palliative care: a need for international collaboration. J Clin Oncol 2008, 26:3867-3873.
4. Rayner L, Price A, Hotopf M, Higginson IJ The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer 2011, published online Jan 6. 10.1016/j.ejca.2010.11.02.
5. Wasteson E, Brenne E, Higginson IJ, et al. Depression assessment and classification in palliative cancer patients: a systematic literature review. Palliat Med 2009, 23:739-753.